HCAP Partners and Baymark Partners Invest in DFW Neuropathy

September 27, 2022

Baymark Partners led an investment in DFW Neuropathy, a North Texas neuropathy treatment clinic, with HCAP Partners joining as an investor. The capital will support DFW Neuropathy’s expansion of its Combination Electroanalgesia Treatment (CET) services across the Dallas–Fort Worth metroplex.

Targets
DFW Neuropathy
Location
Texas, United States
Transaction Type
Growth capital

Explore More

Related Acquisitions

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.